Isogenic human pluripotent stem cell disease models reveal ABRA deficiency underlies cTnT mutation-induced familial dilated cardiomyopathy
Bin Li, Yongkun Zhan, Qianqian Liang, Chen Xu, Xinyan Zhou, Huanhuan Cai, Yufan Zheng, Yifan Guo, Lei Wang, Wenqing Qiu, Baiping Cui, Chao Lu, Ruizhe Qian, Ping Zhou, Haiyan Chen, Yun Liu, Sifeng Chen, Xiaobo Li, Ning Sun
Isogenic human pluripotent stem cell disease models reveal ABRA deficiency underlies cTnT mutation-induced familial dilated cardiomyopathy
[1] |
Arai A, Spencer JA, Olson EN (2002) STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J Biol Chem 277:24453–24459
CrossRef
Google scholar
|
[2] |
Furuya Y, Denda M, Sakane K, Ogusu T, Takahashi S, Magari M, Kanayama N, Morishita R, Tokumitsu H (2016) Identification of striated muscle activator of Rho signaling (STARS) as a novel calmodulin target by a newly developed genome-wide screen. Cell Calcium 60:32–40
CrossRef
Google scholar
|
[3] |
Hershberger RE, Hedges DJ, Morales A (2013) Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 10:531–547
CrossRef
Google scholar
|
[4] |
Jefferies JL, Towbin JA (2010) Dilated cardiomyopathy. The Lancet 375:752–762
CrossRef
Google scholar
|
[5] |
Juan F, Wei D, Xiongzhi Q, Ran D, Chunmei M, Lan H, Chuan Q, Lianfeng Z (2008) The changes of the cardiac structure and function in cTnTR141W transgenic mice. Int J Cardiol 128:83–90
CrossRef
Google scholar
|
[6] |
Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B,Smoot L, Mullen MP, Woolf PK, Wigle ED
CrossRef
Google scholar
|
[7] |
Kathiresan S, Srivastava D (2012) Genetics of human cardiovascular disease. Cell 148:1242–1257
CrossRef
Google scholar
|
[8] |
Kehat I, Molkentin JD (2010) Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122:2727–2735
CrossRef
Google scholar
|
[9] |
Kuwahara K, Teg Pipes GC, McAnally J, Richardson JA, Hill JA, Bassel-Duby R, Olson EN (2007) Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Investig 117:1324–1334
CrossRef
Google scholar
|
[10] |
Lamon S, Wallace MA, Leger B, Russell AP (2009) Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy. J Physiol 587:1795–1803
CrossRef
Google scholar
|
[11] |
McNally EM, Mestroni L (2017) Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res 121:731–748
CrossRef
Google scholar
|
[12] |
Morimoto S, Lu QW, Harada K, Takahashi-Yanaga F, Minakami R, Ohta M,Sasaguri T, Ohtsuki I (2002) Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci USA 99:913–918
CrossRef
Google scholar
|
[13] |
Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M
CrossRef
Google scholar
|
[14] |
Wallace MA, Lamon S, Russell AP (2012) The regulation and function of the striated muscle activator of rho signaling (STARS) protein. Front Physiol 3:469
CrossRef
Google scholar
|
[15] |
Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG
CrossRef
Google scholar
|
/
〈 | 〉 |